Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Neoplasm Female × palbociclib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 29 Neoplasms 8 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Advanced Breast Cancer 3 Sarcoma 2 Prostatic Neoplasms 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Leukemia, Myeloid, Acute 2 Inflammation 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Thromboembolism 1 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Primary Myelofibrosis 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

venetoclax 1 palbociclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡